Novo Nordisk A/S (TSX:NOVO)
Canada · Delayed Price · Currency is CAD 16.26
+0.02 (0.12%)
Oct 6, 2026, 3:50 PM EST
Novo Nordisk Market Cap
Novo Nordisk has a market cap or net worth of CAD 233.03 billion as of October 6, 2026. Its market cap has decreased by -36.90% in one year.
Market Cap
233.03B
Enterprise Value
253.42B
Revenue
71.49B
Ranking
n/a
PE Ratio
9.21
Stock Price
16.26
ChartMarket Cap Chart
Since February 18, 1997, Novo Nordisk's market cap has increased from 9.70B to 233.03B, an increase of 2,302.03%. That is a compound annual growth rate of 11.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 232.74B | -25.28% |
| Dec 30, 2025 | 311.50B | -43.89% |
| Dec 30, 2024 | 555.20B | -8.91% |
| Dec 29, 2023 | 609.54B | 47.94% |
| Dec 30, 2022 | 412.02B | 26.32% |
| Dec 30, 2021 | 326.16B | 56.94% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Apotex Health | 7.12B |
| Curaleaf Holdings | 3.69B |
| Extendicare | 2.62B |
| Sienna Senior Living | 2.17B |
| Green Thumb Industries | 2.07B |
| Cronos Group | 1.71B |
| WELL Health Technologies | 1.15B |
| Knight Therapeutics | 1.02B |